Inactive Instrument

Analyst Reco. Vifor Pharma AG Other OTC

Equities

GNHAY

US92674R1023

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Fitch Pulls Vifor Pharma's Rating After CSL Takeover	22-08-25	MT
Fitch Puts Vifor Pharma on Rating Watch Positive on CSL Takeover	22-06-16	MT
Octavian Lifts Price Target on Vifor Pharma, Maintains Buy Recommendation	21-12-14	MT
Oddo BHF Lifts Price Target on Vifor Pharma, Downgrades Recommendation to Neutral	21-12-14	MT
AlphaValue/Baader Europe Lifts Price Target on Vifor Pharma, Maintains Buy Recommendation	21-12-07	MT
ANALYST RECOMMENDATIONS : Amazon, AMD, Bank of America, Intel, Boeing...	21-11-01
ANALYST RECOMMENDATIONS : BHP, Lear, Naked Wines, Teradata, Visteon...	21-09-20
VIFOR PHARMA : Bank Vontobel Lifts Price Target on Vifor Pharma, Maintains Hold Recommendation	21-08-25	MT
VIFOR PHARMA : Credit Suisse Lifts Price Target on Vifor Pharma, Maintains Outperform Recommendation	21-08-25	MT
ANALYST RECOMMENDATIONS : AMC, AMD, Greggs, Roku, Tesla...	21-08-09
ANALYST RECOMMENDATIONS : Avast, Asos, Compass, Halliburton, Intertek...	21-07-21
VIFOR PHARMA : AlphaValue/Baader Europe Lowers Price Target on Vifor Pharma, Maintains Buy Recommendation	21-06-29	MT
VIFOR PHARMA : AlphaValue/Baader Europe Lifts Price Target on Vifor Pharma, Upgrades Recommendation to Buy from Add	21-06-28	MT
ANALYST RECOMMENDATIONS : Accenture, Comcast, DoorDash, Intel, Roku...	21-06-25
VIFOR PHARMA : Research Partners Downgrades Recommendation on Vifor Pharma To Sell From Hold, Lowers Price Target	21-06-24	MT
VIFOR PHARMA : Research Partners Lowers Price Target on Vifor Pharma, Maintains Hold Recommendation	21-05-06	MT
VIFOR PHARMA : Mirabaud Securities Lifts Price Target on Vifor Pharma, Maintains Buy Recommendation	21-03-08	MT
Vifor Pharma : Fitch Confirms Vifor Pharma at BBB-, Keeps Outlook Stable	21-02-28	MT
VIFOR PHARMA : Octavian Lowers Price Target on Vifor Pharma, Maintains Buy Recommendation	20-11-30	MT
VIFOR PHARMA : Research Partners Maintains Price Target on Vifor Pharma, Initiates Coverage With Hold Recommendation	20-11-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Vifor Pharma AG Other OTC

Equities

GNHAY

US92674R1023

Analyst Reco.

Filters